Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme

Published:2016-03-30 Issue:5 Volume:17 Page:546-557
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Senbabaoglu Filiz,Cingoz Ahmet,Kaya Ezgi,Kazancioglu Selena,Lack Nathan A.,Acilan Ceyda,Bagci-Onder Tugba

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1167292

Reference52 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

2. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide

3. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

4. Targeting TRAIL in the treatment of cancer: new developments

5. Translating TRAIL-receptor targeting agents to the clinic

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics;International Journal of Biological Sciences;2023

2. Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells;Chemotherapy;2023

3. Current approaches in enhancing TRAIL therapies in glioblastoma;Neuro-Oncology Advances;2023-01-01

4. Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors;ACS Pharmacology & Translational Science;2022-12-07

5. The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy;Frontiers in Bioscience-Landmark;2022-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3